1. Home
  2. XERS vs METC Comparison

XERS vs METC Comparison

Compare XERS & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$6.18

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$15.75

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
XERS
METC
Founded
2005
2015
Country
United States
United States
Employees
N/A
900
Industry
Biotechnology: Pharmaceutical Preparations
Coal Mining
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
XERS
METC
Price
$6.18
$15.75
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$10.83
$34.00
AVG Volume (30 Days)
1.6M
1.4M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
0.01
N/A
Revenue
$49,590,000.00
N/A
Revenue This Year
$34.37
$19.61
Revenue Next Year
$22.86
$11.96
P/E Ratio
$633.00
N/A
Revenue Growth
142.67
N/A
52 Week Low
$4.30
$8.51
52 Week High
$10.08
$57.80

Technical Indicators

Market Signals
Indicator
XERS
METC
Relative Strength Index (RSI) 48.72 54.95
Support Level $5.81 $15.08
Resistance Level $6.41 $16.20
Average True Range (ATR) 0.27 1.22
MACD -0.01 0.16
Stochastic Oscillator 40.48 65.95

Price Performance

Historical Comparison
XERS
METC

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

Share on Social Networks: